To investigate whether PLEK2 expression influences immune cell infiltration in human cancers, we performed Estimating the Proportions of Immune and Cancer cells (EPIC) analysis to compare immune scores between patients with high and low PLEK2 expression across 34 cancer types. Here, PLEK2 is linked to cancer.